BRCA2 and breast cancer: The BRCA2 pathogenic variants were significantly prevalent in patients with initial BC (p = 0.006, Fisher Exact test) while BRCA1 pathogenic variants were significantly present in patients with OC (p < 0.001, Fisher Exact test).